ENMC APPROVED 5 WORKSHOP APPLICATIONS

ENMC is happy to announce that 5 workshop applications have been approved in the 2026 Spring review round. These workshops have been planned in January – April 2027.

More details: Workshops 2026-2027

 

 

 

Two new Company Forum members in 2026: argenx and Avidity Biosciences.

We’re excited to share that new companies are joining the ENMC Company Forum in 2026!

A warm welcome to argenx and Avidity Biosciences, Inc., who will be joining our valued partners: Amicus Therapeutics International, Dyne Therapeutics, Lupin Pharmaceuticals, Novartis, Roche, Sanofi, Santhera Pharmaceuticals, and Sarepta Therapeutics.

We are deeply grateful for the continued and growing support of all our partners in advancing our shared mission: connecting people in the neuromuscular field.

Together, we strengthen collaboration, accelerate knowledge exchange, and drive progress for the neuromuscular community.

FSHD Europe – new ENMC Associated Partner

We are thrilled to announce that FSHD Europe has joined as an Associated Partner of the ENMC in 2026, alongside the Österreichische Muskelforschung, SMA Europe, TREAT-NMD, the World Duchenne Organization, and the World Muscle Society. We are grateful for their support in advancing our mission of ‘Connecting People’ within the Neuromuscular field!

New mentees selected for the ENMC Mid-Career Mentoring programme

In the fifth call for the ENMC Mid-Career Mentoring Programme with the deadline July 2025, we received eight applications! Following interviews with each of the candidates, the ENMC Mentoring Programme Committee presented their recommendations to the Research- and Executive Committees. We are very happy to announce that six mentee candidates were selected for the programme:

  • Teresa Gerhalter, PhD, senior scientist at Department of Neurology at the Medical University of Graz, Austria.
  • Clara Gontijo Camelo, MD, PhD, pediatric neurologist at the Faculty of Medicine of the University of São Paulo, Brazil.
  • Felix Kleefeld, MD, PhD, neurologist at the BG University Hospital Bergmannsheil in Bochum, Germany.
  • Mauro Monforte, MD, PhD, neurologist and group leader at the Fondazione Policlinico Universitario A. Gemelli IRCCS, and a researcher at the Catholic University of the Sacred Heart in Rome, Italy.
  • Karlien Mul, MD, PhD, neurologist at Radboud university medical center, Nijmegen, The Netherlands.
  • Rhonda Taylor, PhD, researcher at the Harry Perkins Institute of Medical Research, Perth, Australia.

More information about this programme, follow this link.

New ENMC Research Committee Members

On 1 July 2025, the ENMC welcomed two new Research Committee (RC) members, Prof. Kristl Claeys (Laboratory for Muscle Diseases and Neuropathies, UZ Leuven, Belgium) and Prof. Charlotte Handberg (National Rehabilitation Center for Neuromuscular Diseases (RCFM), Aarhus, Denmark). On 13 November, the RC came together for the autumn Research Committee meeting held at the World Trade Center Schiphol, the Netherlands to discuss the recent submitted workshop applications.

 

ENMC attended the WMS congress

The ENMC had an inspiring and productive time at the World Muscle Society Congress in Vienna, connecting with clinicians, researchers, and experts from across the neuromuscular field. It was a great opportunity to meet with ENMC workshop organisers and participants, (former) ENMC Executive & Research Committee members and (potential) Company Forum partners — and we’re delighted about the new connections made!

A big thank you to everyone who stopped by and showed interest in the ENMC’s activities — your engagement keeps our mission strong. And a huge thank you to the World Muscle Society and the entire WMS team for organizing such a well-run and impactful congress!

ENMC Impact Report 2024 is NOW available!

We are proud to present the ENMC Impact Report 2024! Read about our 2024 activities via this link.

If you would like to receive a printed copy, please send your request to enmc@enmc.org.

ENMC APPROVED 4 WORKSHOP APPLICATIONS

ENMC is happy to announce that 4 workshop applications have been approved in the 2025 Spring review round. These workshops will be planned in Q1 2026.

More details: Workshops 2025-2026

 

TREAT-NMD – new ENMC Associated Partner

We are thrilled to announce that TREAT-NMD has joined as an Associated Partner of the ENMC in 2025, alongside the Österreichische Muskelforschung, SMA Europe, the World Duchenne Organization, and the World Muscle Society. We are grateful for their support in advancing our mission of ‘Connecting People’ within the Neuromuscular field!

ENMC approved 3 workshop applications!

ENMC is happy to announce that 3 workshop applications have been approved in the 2024 Autumn review round. These workshops will be planned in Q2-Q4 2025.

More details: Workshops 2025